, /PRNewswire/ -- The global clinical trial supplies market size is estimated to grow by .31 billion from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of over 8.
65% during the forecast period. Growth of biopharmaceutical industry is driving market growth, with a trend towards growing demand for CROS. However, high cost of clinical trials poses a challenge.
Key market players include Ancillare LP, Avantor Inc., Bionical Emas Group, Bushu Pharmaceuticals Ltd., Catalent Inc.
, Clinical Services International Ltd., Clinigen Group Plc, Deutsche Bahn AG, Emsere B.V, GNH India Pharmaceuticals Ltd.
, International Bonded Couriers Inc., Nuvisan GmbH, Obvio Health Inc., Parexel International Corp.
, PCI Pharma Services, Pharmahandel GmbH and Co KG, Piramal Enterprises Ltd., Precision Medicine Group LLC, Thermo Fisher Scientific Inc., and Vertical Pharma Resources Ltd.
. Get a detailed analysis on regions, market segments, customer landscape, and companies - The clinical trial supplies market is experiencing significant growth due to the increasing outsourcing of clinical trials by pharmaceutical companies to Contract Research Organizations (CROs). This trend is driven by the need to optimize operational costs and focus on research and development.
Developed countries are outsourcing research and testing to emerging economies like and to reduce costs. Key factors fueling market growth include high R&D spending, increasing disease prevalence, and a focus on ra.